About Us
About Conkwest
The human body has an innate ability to defend against cancer. The immune system uses natural killer cells to track down and destroy cancer and other abnormal cells in the body.
Every so often cancer cells develop a characteristic that allows them to escape this part of the immune system and avoid destruction. But Conkwest’s novel cancer-killing products render this evasive characteristic ineffective.
Our proprietary line of natural killer cells aren’t “tricked” by cancer in this fashion, making it lethal against a broad range of cancers, including leukemia, lymphoma, myeloma, melanoma, and cancers of the lung, breast, ovaries, prostate, and brain.
It has demonstrated anti-cancer activity in clinical trials in the US, Canada and Europe while sparing patients from the debilitating toxicities commonly seen with traditional chemotherapies.
Conkwest is developing and commercializing several products based on this powerful cancer-killing cell line.